← Back to news

Eli Lilly Pursues Blocking Order Against Fake Drug Websites

Published: 19 November 2026
Eli Lilly has applied to the High Court for an order requiring major UK internet service providers to block access to websites selling counterfeit or unlicensed versions of its medicines, including Mounjaro and Foundayo. The November 2026 filing alleges trademark infringement and passing off through unauthorised use of marks such as Mounjaro, KwikPen and the company name. It follows successful similar applications by Novo Nordisk that resulted in blocking orders against sites offering fake semaglutide products. The draft order would oblige BT, EE, Plusnet, Sky, TalkTalk and Virgin Media to restrict identified sites, with Lilly responsible for verifying targets and reviewing the list regularly. Most ISPs have indicated they will not oppose the application. The move targets the growing trade in unverified weight-loss medicines, which regulators have warned can contain incorrect ingredients or harmful contaminants.

Small businesses facing online counterfeiting should document misuse of their marks and explore intermediary blocking remedies where evidence supports infringement claims.

Summarised in our own words from public sources.

← Back to news